Vincent Vialou. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Acetylation/drug effectsAnimalsAntidepressive Agents/administration & dosageAntidepressive Agents/pharmacologyAntidepressive Agents/therapeutic useBenzamides/administration & dosageBenzamides/pharmacologyBenzamides/therapeutic useDepressive Disorder/enzymologyDepressive Disorder/geneticsDisease Models, AnimalEpigenesis, Genetic/drug effectsEpigenesis, Genetic/physiologyFluoxetine/administration & dosageFluoxetine/pharmacologyFluoxetine/therapeutic useGene Expression ProfilingGene Expression Regulation/drug effectsGene Expression Regulation/physiologyHistone Acetyltransferases/physiologyHistone Deacetylase Inhibitors/administration & dosageHistone Deacetylase Inhibitors/pharmacologyHistone Deacetylase Inhibitors/therapeutic useHistone Deacetylases/physiologyHistones/metabolismHumansInjectionsMiceNerve Tissue Proteins/biosynthesisNerve Tissue Proteins/geneticsNerve Tissue Proteins/physiologyNucleus Accumbens/drug effectsNucleus Accumbens/enzymologyProtein Processing, Post-Translational/drug effectsPyridines/administration & dosagePyridines/pharmacologyPyridines/therapeutic useStress, Psychological/enzymologyStress, Psychological/genetics
Substances： See more » Antidepressive AgentsBenzamidesHistone Deacetylase InhibitorsHistonesNerve Tissue ProteinsPyridinesFluoxetineentinostatHistone AcetyltransferasesHistone Deacetylases
Year: 2010 PMID： 20510142 DOI： 10.1051/medsci/2010265465
Source DB: PubMed Journal: Med Sci (Paris) ISSN： 0767-0974 Impact factor: 0.818